Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 1
2011 2
2012 1
2013 2
2014 3
2015 4
2016 7
2017 9
2018 27
2019 34
2020 41
2021 38
2022 18
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30543542

177 results

Results by year

Filters applied: . Clear all
Page 1
COMPASS for Vascular Surgeons: Practical Considerations.
Hussain MA, Wheatcroft M, Nault P, Lindsay TF, Bhatt DL, Anand SS, Verma S, Al-Omran M. Hussain MA, et al. Curr Opin Cardiol. 2019 Mar;34(2):178-184. doi: 10.1097/HCO.0000000000000597. Curr Opin Cardiol. 2019. PMID: 30543542 Review.
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S. Anand SS, et al. J Am Coll Cardiol. 2018 May 22;71(20):2306-2315. doi: 10.1016/j.jacc.2018.03.008. Epub 2018 Mar 11. J Am Coll Cardiol. 2018. PMID: 29540326 Free article. Clinical Trial.
Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry.
Lapébie FX, Aboyans V, Lacroix P, Constans J, Boulon C, Messas E, Ferrières J, Bongard V, Bura-Rivière A. Lapébie FX, et al. Eur J Vasc Endovasc Surg. 2021 Sep;62(3):439-449. doi: 10.1016/j.ejvs.2021.05.028. Epub 2021 Jul 28. Eur J Vasc Endovasc Surg. 2021. PMID: 34330647 Free article.
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR. Capell WH, et al. Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3. Am Heart J. 2018. PMID: 29754671 Clinical Trial.
Rivaroxaban in Peripheral Artery Disease after Revascularization.
Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, Mátyás L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR. Bonaca MP, et al. N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28. N Engl J Med. 2020. PMID: 32222135 Clinical Trial.
177 results